Ascendis Pharma A (ASND) Capital Leases (2012)

Ascendis Pharma A's (ASND) quarterly Capital Leases came in at $274941.3 in Q4 2012.

Ascendis Pharma A (ASND) Capital Leases (2012) Analysis & Trends

Ascendis Pharma A has disclosed Capital Leases across 1 years of filings, most recently posting $274941.3 for Q4 2012.

Capital Leases for Q4 2012 came in at $274941.3, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $274941.3 (changed N/A YoY), and the FY2012 annual result was $274941.3, changed N/A from the prior year.
Capital Leases came in at $274941.3 for Q4 2012 at Ascendis Pharma A.
In the past five years, Capital Leases ranged from a high of $274941.3 in Q4 2012 to a low of $274941.3 in Q4 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Ascendis Pharma A	2.75 Bn	2.08 Bn	268.20 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2012	274,941.27